Benedito Matheus Dos Santos

Dr. Benedito Matheus Dos Santos

ICB - Microbiology, University of São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
Benedito Matheus Dos SantosBenedito Matheus Dos Santos
Benedito Matheus Dos Santos
DGDaniel Tadeu Gomes Gonzaga
Daniel Tadeu Gomes Gonzaga
FSFernando de C. da Silva
Fernando de C. da Silva
Vitor ferreiraVitor ferreira
Vitor ferreira
Celia GarciaCelia Garcia
Celia Garcia
The search for new compounds with antimalarial activity is urgent, as resistance to ones in the classical drug, has already been described in more than one continent. Compounds derived from 1,2,3-triazoles are effective against parasites and bacteria. Here, we evaluated the potential antimalarial activity against the human malaria parasite Plasmodium falciparum in a culture of fifty-four triazole compounds derived from 1H-and 2H-1,2,3-triazole. We identified thirty-one compounds with potential antimalarial activity at concentrations in the micromolar order (µM) and IC50 values ranging from 2.80 µM (9) to 29.27 µM (21). Then, we selected some of these compounds to perform the same tests on the PfSR25- strain (knockout for P. falciparum G-protein coupled receptor-like, SR25). Our experiences with the PfSR25- strain showed that both compounds with higher antimalarial activity for the 3D7 strain and those with less activity resulted in lower IC50 values for the knockout strain. The cytotoxicity of the compounds was evaluated in human renal embryonic cells (HEK 293), using MTT assays. This demonstrated that the compounds with the highest activity (9, 13, 19, 22, 24, 29), showed no toxicity at the tested concentrations.

23 July 2020 in Journal of Pineal Research
Verified
Journal Article
Open access
PDF file
BDBárbara Karina de Menezes Dias
Bárbara Karina de Menezes Dias
MNMyna Nakabashi
Myna Nakabashi
MAMarina Rangel Rodrigues Alves
Marina Rangel Rodrigues Alves
DPDanielle Pagliaminuto Portella
Danielle Pagliaminuto Portella
Benedito Matheus Dos SantosBenedito Matheus Dos Santos
Benedito Matheus Dos Santos
Celia GarciaCelia Garcia
Celia Garcia
Melatonin and its indoles derivatives are central in the synchronization of malaria parasites. In this research, we discovered that melatonin is unable to increase the parasitemia in the human malaria Plasmodium falciparum that lacks the kinase PfeIK1. The PfeIK1 knockout strain is a valuable tool in the screening of indol‐related compound that blocks the melatonin effect in wild‐type (WT) parasite development. The assays were performed by using flow cytometry with simultaneous labeling for mitochondria viability with MitoTracker Deep Red and nucleus staining with SYBR Green. We found that Melatotosil leads to an increase in parasitemia in P. falciparum and blocks melatonin effect in the WT parasite. Using microscopy imaging system, we found that Melatotosil at 500 nM is able to induce cytosolic calcium rise in transgenic PfGCaMP3 parasites. On the contrary, the compound Triptiofen blocks P. falciparum cell cycle with IC50 9.76 µM ± 0.6, inhibits melatonin action, and does not lead to a cytosolic calcium rise in PfGCaMP3 parasites. We also found that the synthetic indol‐related compounds arrested parasite cycle for PfeIK1 knockout and (WT) P. falciparum (3D7) in 72 hours culture assays with the IC50 values slighting lower for the WT strain. We concluded that the kinase PfeIK1 is central for melatonin downstream signaling pathways involved in parasite cell cycle progression. More importantly, the indol‐related compounds block its cycle as an upstream essential mechanism for parasite survival. Our data clearly show that this class of compounds emerge as an alternative for the problem of resistance with the classical antimalarials.

1 April 2021 in Toxicon
Verified
Journal Article
Closed access
Benedito Matheus Dos SantosBenedito Matheus Dos Santos
Benedito Matheus Dos Santos
GFGlaucio Monteiro Ferreira
Glaucio Monteiro Ferreira
MTMaurício Tavares
Maurício Tavares
JBJúlio César De Bona
Júlio César De Bona
MHMario Hiroyuki Hirata
Mario Hiroyuki Hirata
MMMirian Machado Mendes
Mirian Machado Mendes

15 March 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
Benedito Matheus Dos SantosBenedito Matheus Dos Santos
Benedito Matheus Dos Santos
BDBárbara K. M. Dias
Bárbara K. M. Dias
MNMyna Nakabashi
Myna Nakabashi
Celia GarciaCelia Garcia
Celia Garcia
Previously we have reported that the G protein-coupled receptor (GPCR)-like PfSR25 in Plasmodium falciparum is a potassium (K+) sensor linked to intracellular calcium signaling and that knockout parasites (PfSR25-) are more susceptible to oxidative stress and antimalarial compounds. Here, we explore the potential role of PfSR25 in susceptibility to the antimalarial compounds atovaquone, chloroquine, dihydroartemisinin, lumefantrine, mefloquine, piperaquine, primaquine, and pyrimethamine and the Medicine for Malaria Venture (MMV) compounds previously described to act on egress/invasion (MMV006429, MMV396715, MMV019127, MMV665874, MMV665878, MMV665785, and MMV66583) through comparative assays with PfSR25- and 3D7 parasite strains, using flow cytometry assays. The IC50 and IC90 results show that lumefantrine and piperaquine have greater activity on the PfSR25- parasite strain when compared to 3D7. For MMV compounds, we found no differences between the strains except for the compound MMV665831, which we used to investigate the store-operated calcium entry (SOCE) mechanism. The results suggest that PfSR25 may be involved in the mechanism of action of the antimalarials lumefantrine and piperaquine. Our data clearly show that MMV665831 does not affect calcium entry in parasites after we depleted their internal calcium pools with thapsigargin. The results demonstrated here shed light on new possibilities on the antimalarial mechanism, bringing evidence of the involvement of the GPCR-like PfSR25.

1 July 2021 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
SVSâmela Alves Pereira Batista Vieira
Sâmela Alves Pereira Batista Vieira
Benedito Matheus Dos SantosBenedito Matheus Dos Santos
Benedito Matheus Dos Santos
CJCélio Dias Santos Júnior
Célio Dias Santos Júnior
VPVanderlúcia Fonseca de Paula
Vanderlúcia Fonseca de Paula
MGMario Sergio Rocha Gomes
Mario Sergio Rocha Gomes
MMMirian Machado Mendes
Mirian Machado Mendes

1 October 2021 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
Benedito Matheus Dos SantosBenedito Matheus Dos Santos
Benedito Matheus Dos Santos
PPPedro Hs Pereira
Pedro Hs Pereira
Celia GarciaCelia Garcia
Celia Garcia